102 related articles for article (PubMed ID: 7036244)
1. [Polychemotherapy associated with oral BCG in the treatment of advanced breast carcinoma. Preliminary observations of a controlled therapeutic trial].
da Silva Neto JB; Fontes CE; Varella D
AMB Rev Assoc Med Bras; 1981 Jul; 27(7):198-9. PubMed ID: 7036244
[No Abstract] [Full Text] [Related]
2. [Polychemotherapy, combined or not to oral BCG, in the treatment of advanced breast cancer: final results of a controlled clinical trial].
Fontes CE; Jaqueto A; da Silva Neto JP; Varella AD; Novo NF
Rev Paul Med; 1987; 105(1):42-6. PubMed ID: 3324269
[No Abstract] [Full Text] [Related]
3. Are surgical adjuvant trials altering the course of breast cancer?
Bonadonna G; Valagussa P; Rossi A; Zucali R; Tancini G; Bajetta E; Brambilla C; De Lena M; Di Fronzo G; Banfi A; Rilke F; Veronesi U
Semin Oncol; 1978 Dec; 5(4):450-64. PubMed ID: 366757
[No Abstract] [Full Text] [Related]
4. The dilemma regarding postoperative chemotherapy in primary carcinoma of the colon.
Weiss RB; DeVita VT
Surg Gynecol Obstet; 1979 Aug; 149(2):267-71. PubMed ID: 380029
[No Abstract] [Full Text] [Related]
5. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
[TBL] [Abstract][Full Text] [Related]
6. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
Chylak V; Ilijas M; Krusić J; Kolarić K
Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
[No Abstract] [Full Text] [Related]
7. Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG.
Britell JC; Ahmann DL; Bisel HF; Frytak S; Ingle JN; Rubin J; O'Fallon JR
Cancer Clin Trials; 1979; 2(4):345-50. PubMed ID: 394870
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
Tormey D; Gelman R; Falkson G
Am J Clin Oncol; 1983 Feb; 6(1):1-18. PubMed ID: 6340458
[No Abstract] [Full Text] [Related]
9. [Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)].
Rabinovich MG; Leone BA; Landó O
Medicina (B Aires); 1981; 41(1):65-70. PubMed ID: 7266359
[No Abstract] [Full Text] [Related]
10. [Chemotherapy in curable breast cancer].
Seradour B; Thomas M
J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):175-82. PubMed ID: 353124
[No Abstract] [Full Text] [Related]
11. Adjuvant therapy of stage II, III breast cancer.
Buzdar AV; Gutterman JU; Blumenschein GR; Tashima CK; Hortobágyi GN; Yap HY; Hersh EM; Gehan EA
Recent Results Cancer Res; 1978; 68():123-8. PubMed ID: 379930
[No Abstract] [Full Text] [Related]
12. [Advanced carcinoma of the breast. Results of a polychemotherapeutic protocol].
Fazio M; Manca A; Rodino A; Cavallero P; Tripodina A
Minerva Ginecol; 1982 Sep; 34(9):667-70. PubMed ID: 7145204
[No Abstract] [Full Text] [Related]
13. Clinical controlled trial in advanced breast cancer: CMFV (cyclophosphamide, methotrexate, fluorouracil, vincristine) verus CD (carminomycin, dibromodulcitol).
Neoplasma; 1982; 29(6):741-7. PubMed ID: 6761595
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
[No Abstract] [Full Text] [Related]
15. [Combination chemotherapy in advanced carcinoma of the breast].
Carmo-Pereira J; Galvão-Teles A; Oliveira Costa F; Bak Gordon R; Henriques E; Dória JM; Freire Cruz M; Silveira Botelho L
Arq Patol; 1974; 46(2-3):309-23. PubMed ID: 4458643
[No Abstract] [Full Text] [Related]
16. Advances in the multimodal primary management of cancer.
DeVita VT; Henney JE; Weiss RB
Adv Intern Med; 1980; 26():115-29. PubMed ID: 7013437
[No Abstract] [Full Text] [Related]
17. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
Cowan K; Lippman M
Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
[No Abstract] [Full Text] [Related]
18. [Results of "5-drug" treatment of advanced breast cancer].
Dorociak R
Pol Tyg Lek; 1981 Sep; 36(38):1467-70. PubMed ID: 7329862
[No Abstract] [Full Text] [Related]
19. [Results of 5-fluorouracil, methotrexate, cyclophosphamide and prednisone combination therapy in the treatment of advanced breast cancer].
García Puche JL; Ballesteros P; Cueto J; Mendiola C; Rodríguez PA; Talavera MC
Rev Clin Esp; 1979 Feb; 152(3):203-8. PubMed ID: 441472
[No Abstract] [Full Text] [Related]
20. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
Heuson JC; Paridaens R
Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
[No Abstract] [Full Text] [Related]
[Next] [New Search]
